An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Bone marrow mesenchymal stem/stromal cells (BMSCs), which are known as multipotent cells, are widely used in the treatment of various diseases via their self-renewable, differentiation, and immunomodulatory properties. In-vitro and in-vivo studies have supported the understanding mechanisms, safety, and efficacy of BMSCs therapy in clinical applications. The number of clinical trials in phase I/II is accelerating; however, they are limited in the size of subjects, regulations, and standards for the preparation and transportation and administration of BMSCs, leading to inconsistency in the input and outcome of the therapy. Based on the International Society for Cellular Therapy guidelines, the characterization, isolation, cultivation, differentiation, and applications can be optimized and standardized, which are compliant with good manufacturing practice requirements to produce clinical-grade preparation of BMSCs. This review highlights and updates on the progress of production, as well as provides further challenges in the studies of BMSCs, for the approval of BMSCs widely in clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206 · cited 1×
“In vitro and in vivo studies have reported stimulation of tumor growth by providing supportive stroma, creating a permissive environment and/or reducing immune rejection of tumor cells [127,128].”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation Research · doi:10.1161/01.res.0000118601.37875.ac · Cited by 1,415 · cited 4×
“%) or growth factors, such as TGF-β, FGF2, or PGFEP, can be supplied in the media instead of serum.”
InfluentialStolzing, A., Jones, E., McGonagle, D., & Scutt, A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.002 · Cited by 1,195 · cited 2×
“had shown age-related changes in BMSCs, consisting of stem cell number, marker phenotype, proliferation, differentiation potential, senescence and apoptosis induction, and stress level markers [35].”
BackgroundImmunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166 · cited 1×
“In vitro and in vivo studies have reported stimulation of tumor growth by providing supportive stroma, creating a permissive environment and/or reducing immune rejection of tumor cells [127,128].”
BackgroundSoldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728
Immunosuppressive properties of mesenchymal stem cells: advances and applications
P. De Miguel, M., Fuentes-Julian, S., Blazquez-Martinez, A., Y. Pascual, C., A. Aller, M., Arias, J., & Arnalich-Montiel, F. (2012) · Current Molecular Medicine · doi:10.2174/156652412800619950 · Cited by 660
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Zhang, X., Sai, B., Wang, F., Wang, L., Wang, Y., Zheng, L., Li, G., Tang, J., & Xiang, J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0959-5 · Cited by 560
Suk, K. T., Yoon, J., Kim, M. Y., Kim, C. W., Kim, J. K., Park, H., Hwang, S. G., Kim, D. J., Lee, B. S., Lee, S. H., et al. (2016) · Hepatology · doi:10.1002/hep.28693 · Cited by 303 · cited 9×
“Autologous and allogeneic BMSCs both can be used in clinical trials and exhibit positive results.”
BackgroundInfluentialKim, Y. J., Kim, H. K., Cho, H. H., Bae, Y. C., Suh, K. T., & Jung, J. S. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110447 · Cited by 298 · cited 1×
“Remodeling of extracellular matrix Metalloproteinase 9 (MMP9) [52]”
BackgroundLin, B., Chen, J., Qiu, W., Wang, K., Xie, D., Chen, X., Liu, Q., Peng, L., Li, J., Mei, Y., et al. (2017) · Hepatology · doi:10.1002/hep.29189 · Cited by 288 · cited 5×
“Diseases Pre-ClinicalStudies Clinical Trials Routine Treatment Effect of BMSCs Therapy Autologous or Allogenous Ref.”
BackgroundInfluentialChen, L., Xu, Y., Zhao, J., Zhang, Z., Yang, R., Xie, J., Liu, X., & Qi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096161 · Cited by 251 · cited 1×
“Vascular endothelial growth factor (VEGF) [54]”
Wu, M., Zhang, R., Zou, Q., Chen, Y., Zhou, M., Li, X., Ran, R., & Chen, Q. (2018) · Scientific Reports · doi:10.1038/s41598-018-23396-1 · Cited by 206
Bhansali, S., Dutta, P., Kumar, V., Yadav, M. K., Jain, A., Mudaliar, S., Bhansali, S., Sharma, R. R., Jha, V., Marwaha, N., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0275 · Cited by 126
Transplantation of mesenchymal stem cells from young donors delays aging in mice
Shen, J., Tsai, Y.-T., DiMarco, N. M., Long, M. A., Sun, X., & Tang, L. (2011) · Scientific Reports · doi:10.1038/srep00067 · Cited by 117 · cited 1×
“Transplantation young BMSCs can also extend life span when compared to non-transplantation and old BMSCs transplantation group [34].”
BackgroundThe role of bone marrow derived mesenchymal stem cells in sports injuries
Vris, A., Aresti, N., Khan, W. S., & Malik, A. A. (2016) · Stem Cells in Clinical Applications · doi:10.1007/978-3-319-40144-7_14 · Cited by 28 · cited 1×
“Besides, BMSCs is also intended in the treatment of sports injuries [177,178].”
Background
Cited by
Zhou, Q., Rong, C., Gu, T., Li, H., Wu, L., Zhuansun, X., Zhao, X., Xiao, Z., Kuang, Y., Xu, S., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03030-8 · Cited by 43
miR-188-3p targets skeletal endothelium coupling of angiogenesis and osteogenesis during ageing
He, W.-Z., Yang, M., Jiang, Y., He, C., Sun, Y.-C., Liu, L., Huang, M., Jiao, Y.-R., Chen, K.-X., Hou, J., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04902-w · Cited by 30
Si, Z., Zhao, S., Zhang, Z., Chen, T., Wang, R., Dong, C., Wang, K., Sun, C., Song, Z., Shen, Z., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04353-y · Cited by 10
Liu, Z., Jiang, X., You, H., Tang, Z., Ma, Y., Che, N., Liu, W., & Ma, C. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05152-4 · Cited by 4
“Furthermore, studies have suggested that BMSCs can attenuate liver fibrosis by secreting various growth factors that promote liver repair, such as PGE2 and B7-H4 [6].”
Liu, F.-Y., Shi, M., Li, X., Yuan, H.-J., Tian, X.-M., Xia, Y.-M., Zhou, M., & Wang, F.-S. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00580 · Cited by 3
Metadata
- Authors
- Chu, D.-T., Phuong, T. N. T., Tien, N. L. B., Tran, D. K., Thanh, V. V., Quang, T. L., Truong, D. T., Pham, V. H., Ngoc, V. T. N., Chu-Dinh, T., & Kushekhar, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-01-21
- Volume
- 21
- Issue
- 3
- Pages
- 708
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3001407741
- Cited by
- 236
- References
- 19
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.